Concentrix (NASDAQ:CNXC) Given “Buy” Rating at Canaccord Genuity Group

Concentrix (NASDAQ:CNXC)‘s stock had its “buy” rating reiterated by Canaccord Genuity Group in a report released on Wednesday, Benzinga reports. They currently have a $45.00 price target on the stock. Canaccord Genuity Group’s target price would indicate a potential upside of 69.20% from the company’s current price.

Several other brokerages also recently issued reports on CNXC. Zacks Research upgraded Concentrix from a “strong sell” rating to a “hold” rating in a research report on Monday, August 31st. Robert W. Baird reduced their price objective on shares of Concentrix from $40.00 to $30.00 and set an “outperform” rating for the company in a research note on Tuesday, June 30th. Barrington Research dropped their price target on shares of Concentrix from $38.00 to $30.00 and set an “outperform” rating for the company in a research note on Tuesday, June 30th. Bank of America dropped their target price on shares of Concentrix from $32.00 to $26.00 and set a “neutral” rating on the stock in a research note on Tuesday, June 30th. Finally, Weiss Ratings reissued a “sell (d)” rating on shares of Concentrix in a research report on Friday, July 24th. Three equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average price target of $32.75.

Concentrix Stock Up 6.9%

Shares of CNXC traded up $1.72 during trading hours on Wednesday, hitting $26.60. The company had a trading volume of 2,303,016 shares, compared to its average volume of 1,638,495. The stock has a market capitalization of $1.62 billion, a price-to-earnings ratio of -1.25, a P/E/G ratio of 0.47 and a beta of 0.47. Concentrix has a 52-week low of $19.12 and a 52-week high of $49.37. The firm has a fifty day moving average price of $27.01 and a 200-day moving average price of $26.53. The company has a debt-to-equity ratio of 1.46, a quick ratio of 1.18 and a current ratio of 1.18.

Concentrix (NASDAQ:CNXC) last announced its quarterly earnings data on Tuesday, September 29th. The company reported $2.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.71 by $0.21. Concentrix had a positive return on equity of 19.82% and a negative net margin of 13.16%.The firm had revenue of $2.45 billion during the quarter, compared to analysts’ expectations of $2.48 billion. During the same period last year, the business posted $2.78 earnings per share. The company’s revenue for the quarter was down 1.2% compared to the same quarter last year. Concentrix has set its FY 2026 guidance at 10.970-11.090 EPS and its Q4 2026 guidance at 2.860-2.980 EPS. On average, equities research analysts forecast that Concentrix will post 9.67 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the stock. BlackRock Inc. bought a new stake in shares of Concentrix during the second quarter worth $149,639,000. Dimensional Fund Advisors LP grew its holdings in Concentrix by 18.5% during the first quarter. Dimensional Fund Advisors LP now owns 2,951,378 shares of the company’s stock valued at $80,746,000 after purchasing an additional 460,108 shares during the period. Pzena Investment Management LLC raised its position in Concentrix by 0.5% during the first quarter. Pzena Investment Management LLC now owns 2,943,212 shares of the company’s stock valued at $80,526,000 after purchasing an additional 16,016 shares in the last quarter. Groupe Bruxelles Lambert bought a new position in shares of Concentrix during the second quarter valued at about $68,000,000. Finally, Kopernik Global Investors LLC purchased a new position in shares of Concentrix during the first quarter valued at approximately $44,523,000. Institutional investors and hedge funds own 90.34% of the company’s stock.

Key Headlines Impacting Concentrix

Here are the key news stories impacting Concentrix this week:

• Positive Sentiment: Concentrix reported third-quarter adjusted earnings of $2.92 per share, exceeding the $2.71 analyst consensus and rising from $2.78 a year earlier. The company also exceeded its profitability guidance. Concentrix Corporation Q3 Earnings Beat Estimates
• Positive Sentiment: Operating cash flow reached a quarterly record of $268 million, while adjusted free cash flow was $218 million, supporting capital returns and balance-sheet management. Concentrix Reports Third Quarter 2026 Results
• Positive Sentiment: The quarterly dividend was raised 2.8% to $0.37 per share, or $1.48 annualized, providing an indicated yield of approximately 5.6%. Concentrix Reports Third Quarter 2026 Results
• Neutral Sentiment: Full-year EPS guidance of $10.97-$11.09 is above the $10.89 consensus, but fiscal-year revenue guidance of $9.8-$9.9 billion trails the $10.0 billion estimate.
• Negative Sentiment: Third-quarter revenue of $2.45 billion missed the $2.48 billion consensus and declined 1.2% year over year. Investors are concerned that the transition toward AI-related services is weighing on current revenue. Concentrix Stock Falls After Earnings as AI Transition Weighs on Revenue
• Negative Sentiment: Fourth-quarter EPS guidance of $2.86-$2.98 and revenue guidance of $2.4-$2.5 billion both came in below analyst expectations of $3.08 and $2.5 billion, respectively.

Concentrix Company Profile

Concentrix Corporation is a global technology and services company that helps organizations manage customer experience, business operations and digital transformation. Its offerings include customer care, technical support, sales and marketing services, back-office support, analytics, artificial intelligence and automation solutions.

The company serves clients across industries such as technology and consumer electronics, retail, banking and financial services, healthcare, communications and media, travel, and automotive.